Clinical and translational results of the myeloma developing regimens using genomics (MyDRUG) sub-protocol C1 targeting RAS mutations Meeting Abstract


Authors: Kumar, S.; Jayasinghe, R.; Bianchi, G.; Biran, N.; Hultcrantz, M.; Richter, J.; Vij, R.; Ye, C.; Zonder, J.; DeLello, L.; Mulligan, G.; Yesil, J.; Cho, H.
Abstract Title: Clinical and translational results of the myeloma developing regimens using genomics (MyDRUG) sub-protocol C1 targeting RAS mutations
Meeting Title: 19th International Myeloma Society Annual Meeting (IMS)
Journal Title: Clinical Lymphoma, Myeloma and Leukemia
Volume: 22
Issue: Suppl.
Meeting Dates: 2022 Aug 25-27
Meeting Location: Los Angeles, CA
ISSN: 2152-2650
Publisher: Elsevier Inc.  
Date Published: 2022-08-01
Start Page: S29
Language: English
ACCESSION: WOS:000895909200048
PROVIDER: wos
DOI: 10.1016/S2152-2650(22)00320-2
Notes: Meeting Abstract: OAB-047 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors